Literature DB >> 30382405

Management of Episodic Migraine in Children and Adolescents: a Practical Approach.

Reena Gogia Rastogi1, Clarimar Borrero-Mejias2, Carolyn Hickman2, Kara Stuart Lewis2, Robert Little2.   

Abstract

PURPOSE OF REVIEW: Episodic migraine is very common in children and adolescents, seen by primary care and specialists. In kids, this can greatly affect quality of life, including significant disability, specifically in terms of missed school and other activities. The goal of this paper is to give an overview of the most up-to-date thoughts on episodic migraine in the pediatric population. RECENT
FINDINGS: Current options for both abortive and preventative treatments in kids, as well as specific non-pharmacological and lifestyle management recommendations for children, will be reviewed, as well as options for status migrainosus in the pediatric patient. Migraine pathophysiology is similar in adults and children with episodic migraine, but the approach to the management needs to be modified and adjusted in kids. Recognizing the impact on quality of life especially with regard to school and knowing appropriate treatment options can improve treatment and decrease the disability from this disorder.

Entities:  

Keywords:  Lifestyle management in pediatric migraine; Migraine; Non-pharmacological treatment modalities in pediatric migraine; Pediatric episodic migraine; Pediatric migraine; Triptans

Mesh:

Year:  2018        PMID: 30382405     DOI: 10.1007/s11910-018-0900-0

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  64 in total

1.  Patterns of Use of Peripheral Nerve Blocks and Trigger Point Injections for Pediatric Headache: Results of a Survey of the American Headache Society Pediatric and Adolescent Section.

Authors:  Christina L Szperka; Amy A Gelfand; Andrew D Hershey
Journal:  Headache       Date:  2016-10-12       Impact factor: 5.887

2.  Recommended Amount of Sleep for Pediatric Populations: A Consensus Statement of the American Academy of Sleep Medicine.

Authors:  Shalini Paruthi; Lee J Brooks; Carolyn D'Ambrosio; Wendy A Hall; Suresh Kotagal; Robin M Lloyd; Beth A Malow; Kiran Maski; Cynthia Nichols; Stuart F Quan; Carol L Rosen; Matthew M Troester; Merrill S Wise
Journal:  J Clin Sleep Med       Date:  2016-06-15       Impact factor: 4.062

3.  Nonpharmacologic treatment of migraine with low-dose propranolol or amitriptyline.

Authors:  Tal Eidlitz-Markus; Yael Dlugatch; Yishai Haimi-Cohen; Hadassa Goldberg-Stern; Avraham Zeharia
Journal:  Pediatr Neurol       Date:  2012-06       Impact factor: 3.372

Review 4.  Efficacy of biofeedback for migraine: a meta-analysis.

Authors:  Yvonne Nestoriuc; Alexandra Martin
Journal:  Pain       Date:  2006-11-02       Impact factor: 6.961

Review 5.  Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society.

Authors:  D Lewis; S Ashwal; A Hershey; D Hirtz; M Yonker; S Silberstein
Journal:  Neurology       Date:  2004-12-28       Impact factor: 9.910

6.  Population-based study of migraine in Spanish adults: relation to socio-demographic factors, lifestyle and co-morbidity with other conditions.

Authors:  César Fernández-de-Las-Peñas; Valentín Hernández-Barrera; Pilar Carrasco-Garrido; Cristina Alonso-Blanco; Domingo Palacios-Ceña; Silvia Jiménez-Sánchez; Rodrigo Jiménez-García
Journal:  J Headache Pain       Date:  2009-12-10       Impact factor: 7.277

7.  Divalproex extended-release in adolescent migraine prophylaxis: results of a randomized, double-blind, placebo-controlled study.

Authors:  George Apostol; Roger K Cady; Genevieve A Laforet; Weining Z Robieson; Evelyn Olson; Walid M Abi-Saab; Mario Saltarelli
Journal:  Headache       Date:  2008-07       Impact factor: 5.887

8.  Biofeedback treatment for headache disorders: a comprehensive efficacy review.

Authors:  Yvonne Nestoriuc; Alexandra Martin; Winfried Rief; Frank Andrasik
Journal:  Appl Psychophysiol Biofeedback       Date:  2008-08-26

9.  Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age.

Authors:  Donald Lewis; Paul Winner; Joel Saper; Seth Ness; Elena Polverejan; Steven Wang; Caryn L Kurland; Jeff Nye; Eric Yuen; Marielle Eerdekens; Lisa Ford
Journal:  Pediatrics       Date:  2009-03       Impact factor: 7.124

10.  Intravenous magnesium as acute treatment for headaches: a pediatric case series.

Authors:  Emily Gertsch; Sheila Loharuka; Kristine Wolter-Warmerdam; Suhong Tong; Allison Kempe; Sita Kedia
Journal:  J Emerg Med       Date:  2013-10-29       Impact factor: 1.484

View more
  1 in total

1.  Identification of neural and psychophysical predictors of headache reduction after cognitive behavioral therapy in adolescents with migraine.

Authors:  Hadas Nahman-Averbuch; Victor J Schneider; Leigh Ann Chamberlin; Ashley M Kroon Van Diest; James L Peugh; Gregory R Lee; Rupa Radhakrishnan; Andrew D Hershey; Scott W Powers; Robert C Coghill; Christopher D King
Journal:  Pain       Date:  2021-02-01       Impact factor: 7.926

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.